Bell-Kenz Pharma admits giving incentives to doctors

Bell-Kenz Pharma admits giving incentives to doctors

MANILA, Philippines – Bell-Kenz Pharma Inc. admitted on Tuesday to “giving incentives” to some of its doctor partners but denied allegations of involvement in so-called “multi-level marketing schemes” or MLMs.

The firm’s chairperson and chief executive officer Luis Raymond Go disclosed this himself during a hearing of the Senate panel on health and demography.

READ: Bell-Kenz Pharma executive appears before Senate probe

“We are giving incentives and…support to our doctors for them to include us as a brand for their generic prescriptions. We give them continuing medical education locally and abroad, and sometimes we also provide them with clinic equipment,” said Go.

Senator Jinggoy Estrada, who earlier disclosed that physicians conniving with Bell-Kenz are earning around P2 million based on their productivity, asked if they pay for trips for their partner doctors.

To this, Go said yes. He, however, denied giving cash and gifting luxury cars to their partner doctors.

READ: Jinggoy Estrada fleshes out multi-million doctors-pharma collusion

While he admitted that Bell-Kenz gives “incentives,” Go maintained that the firm is law-abiding.

“We offer hope even in the face of illness, ensuring that both dependable and affordable for all. In recent days, our company has found itself in a web of misinformation propagated through various media channels.

“I stand before this assembly to vehemently refuse these baseless allegations and to reaffirm our unwavering commitment to integrity and compliance,” said Go.

READ: BELL-KENZ, a target of competitors?

“Let me unequivocally assert the following truth about Bell-Kenz Pharma: we are a law-abiding pharmaceutical entity diligently adhering to all regulations set by the FDA, SEC, PMA, and other relevant governing bodies.

‘We operate in a pharmaceutical marketing method and ensure that we do it in transparency, ethical integrity with our practices upholding the highest standards of corporate conduct,” he added.